M R. Yazdi-Maleki
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Primary Care Severe Asthma Registry and Education Project (PCSAR-EDU): Phase 1 - an e-Delphi for registry definitions and indices of clinician behaviour.
Journal: BMJ open
Published: March 25, 2022
Importance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care.
Journal: Canadian family physician Medecin de famille canadien
Published: September 15, 2021
Title Not Found
Journal: Canadian family physician Medecin de famille canadien
Published: September 15, 2021
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD.
Journal: Pulmonary therapy
Published: December 13, 2018
Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD.
Journal: Advances in therapy
Published: October 26, 2018
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology.
Journal: International journal of chronic obstructive pulmonary disease
Published: September 21, 2018
Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol.
Journal: NPJ primary care respiratory medicine
Published: February 07, 2017
Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 23, 2016
Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
Journal: Advances in therapy
Published: July 14, 2015
Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial.
Journal: Respiratory medicine
Published: June 27, 2014
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD.
Journal: Respiratory medicine
Published: March 28, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026